Aptorum Group Limited (NASDAQ:APM) Sees Significant Drop in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the recipient of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 58,500 shares, a decline of 49.3% from the February 13th total of 115,400 shares. Currently, 1.3% of the company’s shares are short sold. Based on an average daily volume of 2,240,000 shares, the days-to-cover ratio is presently 0.0 days.

Aptorum Group Price Performance

Shares of NASDAQ:APM opened at $0.90 on Friday. Aptorum Group has a 1-year low of $0.46 and a 1-year high of $11.95. The business has a 50-day moving average price of $1.16 and a two-hundred day moving average price of $1.44.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.